| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ayala Pharmaceuticals, Inc. (ADXS) has 0 insiders with recent SEC Form 4 filings, including 4 buys and 9 sells. ADXS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 18, 2023 | Israel Biotech Fund I, L.P. | 10% Owner | Buy | 1,317,716 | $0.00 | - | +55.8% | |
| Mar 13, 2020 | Appel Roni | Director | Sell | 3,000 | $0.57 | $1,703.88 | -7.6% | |
| Apr 10, 2019 | Appel Roni | Director | Buy | 3,000 | $3.80 | $11,391.00 | +28.6% | |
| Nov 5, 2018 | Petit Robert | Chief Scientific Officer | Sell | 3,963 | $0.58 | $2,298.54 | -1.7% | |
| Nov 2, 2018 | Petit Robert | Chief Scientific Officer | Sell | 8,491 | $0.56 | $4,754.96 | -3.5% | |
| Sep 11, 2018 | Appel Roni | - | Buy | 33,333 | $1.20 | $39,999.60 | +26.9% | |
| Apr 2, 2018 | Petit Robert | Chief Scientific Officer | Sell | 2,193 | $1.62 | $3,552.66 | -1.0% | |
| Feb 2, 2018 | Lombardo Anthony A | Interim CEO | Sell | 32 | $2.93 | $93.76 | - | |
| Jan 3, 2018 | Bonstein Sara | Chief Financial Officer | Sell | 5,224 | $3.18 | $16,612.32 | -2.3% | |
| Nov 6, 2017 | Petit Robert | Chief Scientific Officer | Sell | 3,723 | $3.30 | $12,285.90 | -1.7% |